Lansoprazole promotes cisplatin‐induced acute kidney injury via enhancing tubular necroptosis

Acute kidney injury (AKI) is the main obstacle that limits the use of cisplatin in cancer treatment. Proton pump inhibitors (PPIs), the most commonly used class of medications for gastrointestinal complications in cancer patients, have been reported to cause adverse renal events. However, the effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Lin, Pang, Wanxia, Huang, Yanheng, Wu, Hongluan, Huang, Xiaorong, Liu, Jianxing, Wang, Shujun, Yang, Chen, Pan, Qingjun, Liu, Huafeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933939/
https://www.ncbi.nlm.nih.gov/pubmed/33605079
http://dx.doi.org/10.1111/jcmm.16302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933939/
https://www.ncbi.nlm.nih.gov/pubmed/33605079
http://dx.doi.org/10.1111/jcmm.16302

Ejemplares similares